Related Experiment Videos
Glaucoma pharmacotherapy: implications for flying fitness
1Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore 168751. vpmlam@yahoo.com.sg
Aviation, Space, and Environmental Medicine
|August 23, 2005
Summary
Glaucoma treatment has expanded with new medications, reducing the need for surgery. However, aircrew must consider potential medication side effects that could impact flight safety.
Area of Science:
- Ophthalmology
- Aerospace Medicine
Background:
- Intraocular pressure (IOP) management is central to glaucoma therapy.
- Historically, limited pharmacotherapies like timolol, pilocarpine, and acetazolamide were available.
Purpose of the Study:
- To review the evolution of glaucoma pharmacotherapy.
- To highlight the implications of new glaucoma medications for aviation medicine.
Main Methods:
- Literature review of glaucoma treatment advancements.
- Analysis of medication side effect profiles relevant to aircrew.
Main Results:
- A significant increase in available glaucoma medications has occurred.
- The number of glaucoma surgeries has decreased due to effective pharmacotherapy.
- Certain glaucoma medications possess side effects potentially disqualifying for aircrew.
Conclusions:
- Modern glaucoma pharmacotherapy offers more options but requires careful consideration of side effects.
- Aviation medical practitioners must be aware of these adverse effects to ensure aircrew safety.